eLetter: Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors by M Genovese
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is application/pdf.
Areti Triantafyllou, Athina Pyrpasopoulou, Panagiota Anyfanti, Ekaterini Balaska, Spyros Aslanidis, Stella Douma. "eLetter: Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors by M Genovese." Annals of the Rheumatic Diseases 72.5 (2013) e7-e7